<DOC>
	<DOCNO>NCT01241968</DOCNO>
	<brief_summary>Low intensity shockwaves proven animal study induce local growth new blood vessel exist one . The hypothesis study shockwave therapy could improve symptom patient refractory angina amenable revascularization angioplasty bypass surgery .</brief_summary>
	<brief_title>Extracorporeal Shock Wave Therapy Treatment Ischemic Heart Disease</brief_title>
	<detailed_description>Low intensity shockwaves ( 1/10 one use Lithotripsy ) deliver myocardial ischemic tissue . Shockwaves create special generator focus use shockwave applicator device . The treatment guide standard echocardiography equipment . The shockwaves deliver synchronization Patient R-wave avoid arrhythmia . The treatment painless . At first , patient undergoes Stress-Echocardiography test identify hypokinetic area ( ischemic area ) . Following , ischemic area sre treat shockwaves . Several treatment require optimal result .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Patient diagnose chronic stable angina pectoris . Diagnosis base medical history , complete physical evaluation . Patient document myocardial segment reversible ischemia . Patient classify AP CCS IIIIV . Patient stable dosage medication use treat angina least 6 week prior enrollment . Patient demonstrate exercise tolerance capacity high 125 W modify Bruce treadmill exercise test presence clinical symptom ( i.e . angina , STdepression ) . Patient demonstrate exercise tolerance time stability average 25 % ( test perform within two week least day different two ) . Patient document epicardial coronary artery disease amenable angioplasty CABG . Patient sign IRB approve informed consent form . Patient 's condition stable life expectancy &gt; 12 month . Patient 's current past medical condition status assess use previous medical history , physical evaluation , physician ( principle investigator 's ) medical opinion . Patient pregnant Patient chronic lung disease include emphysema pulmonary fibrosis . Patient active endocarditis , myocarditis pericarditis . Patient simultaneously participate another device drug study , participate clinical trial involve experimental device drug , include drug device enhance cardiac neovascularization , ESWT machine competitor company within 3 month entry study . Patients unwilling unable cooperate study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Extracorporeal Shockwave Therapy</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Refractory Angina</keyword>
</DOC>